The state-supported Institute will bring a comprehensive approach to brain injury. Read More
Dr. Goldberg’s research focuses on identifying the mechanisms of neuronal degeneration in Parkinson’s disease. Read More
Dr. Gebreyohanns works to provide stroke education throughout the community. Read More
Darin Okuda, M.D. and his colleagues conducting a multi-national study found that individuals with radiologically isolated syndrome (RIS) are at risk for a first clinical attack related to demyelination within the central nervous system; the risk appears to be predicated on age, sex, and the presence of cervical or thoracic spinal cord lesions.
Divyanshu Dubey, M.D., neurology resident, presented two papers at the 2014 International Stroke Conference. Dr. Dubey's work research focused on a combination therapy for ischemic stroke and smartphone applications for stroke.
Susan Iannaccone, M.D.'s, clinical trial of a drug for children with Spinal Muscular Atrophy (SMA) has had promising results. The drug manufacturer, ISIS Pharmaceuticals, reported the drug was well-tolerated at all dose levels and improved disease characteristics. Phase 3 trials are planned for later this year.
- Added March 03, 2014 - Neurology
Teresa Frohman, PA-C, Multiple Sclerosis Program, received the Diana and Richard C. Strauss Award for clinical employee excellence.Added February 13, 2014 - Awards